Literature DB >> 32246164

Personality traits predict residual pain after total hip and knee arthroplasty.

Michele Mercurio1, Giorgio Gasparini2, Elvira Anna Carbone3, Olimpio Galasso1, Cristina Segura-Garcia4.   

Abstract

AIM OF THE STUDY: We assessed the role of personality traits, anxiety, and depression in residual pain among patients who underwent total hip (THA) and knee (TKA) arthroplasty.
METHOD: Eighty-three patients (40 THA and 43 TKA) were interviewed pre-operatively (t0); five days (t1) after surgery; and one (t2), three (t3), six (t4), and 12 months (t5) after surgery. Personality (TCI-R), pain (VAS), anxiety and depression (HADS), quality of life (SF-12), functionality (HHS/KSS), and disability (WOMAC) were evaluated.
RESULTS: Pain reduction and functional improvement were reported at t5 (both p < 0.001) in both THA and TKA patients. THA patients showed earlier and greater functional improvement after surgery (both p < 0.001) in comparison with TKA. Residual pain (VAS > 30 mm) was noted in 15% of the THA patients and 25% of the TKA patients, and it correlated with the SF-12 PCS (r2 = - 0.412; p < 0.001), SF-12 MCS (r2 = - 0.473; p < 0.001), HADS-A (r2 = 0.619; p = <0.001), HADS-D (r2 = 0.559; p < 0.001), functionality (r2 = - 0.482; p < 0.001), and WOMAC (r2 = 0.536; p < 0.001) scores at t5. High pre-operative harm avoidance, persistence, and anxiety scores were predictive of residual pain after both THA and TKA (p < 0.001). DISCUSSION: The proportion of patients complaining of residual pain in this study was similar to that in previous findings. Multiple predictors of residual pain after THA and TKA have been previously described, and several studies evaluated the influence of psychological factors on the outcome of joint arthroplasty; however, only four studies investigated the role of personality traits in the outcome of THA and TKA patients, and a unique study out of these investigations demonstrated the effect of personality on persisting pain.
CONCLUSION: The current study demonstrated that personality traits and anxiety predict residual pain; thus, pre-operative evaluation of these factors could be helpful in identifying patients at risk for residual pain.

Entities:  

Keywords:  Anxiety; Depression; Personality traits; Residual pain; Total hip arthroplasty; Total knee arthroplasty

Mesh:

Year:  2020        PMID: 32246164     DOI: 10.1007/s00264-020-04553-6

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  5 in total

Review 1.  Trend of Perioperative CRP (C-Reactive Protein) Levels in Non-Infected Total Knee Arthroplasty.

Authors:  Michele Mercurio; Olimpio Galasso; Filippo Familiari; Bruno Iannò; Carmine Fabio Bruno; Davide Castioni; Giorgio Gasparini
Journal:  Orthop Rev (Pavia)       Date:  2022-06-29

Review 2.  Outcomes of Bi-unicompartmental Versus Total Knee Arthroplasty for the Treatment of Medial and Lateral Knee Osteoarthritis: A Systematic Review and Meta-analysis of Comparative Studies.

Authors:  Michele Mercurio; Giorgio Gasparini; Filippo Familiari; Davide Castioni; Olimpio Galasso
Journal:  Indian J Orthop       Date:  2022-04-06       Impact factor: 1.033

3.  Pain medication purchases before and after total hip and knee arthroplasty: a register study of 329,743 arthroplasties.

Authors:  Ville Turppo; Reijo Sund; Jukka Huopio; Heikki Kröger; Joonas Sirola
Journal:  Acta Orthop       Date:  2022-06-08       Impact factor: 3.925

4.  Excellent Functional Outcome and Quality of Life after Primary Cementless Total Hip Arthroplasty (THA) Using an Enhanced Recovery Setup.

Authors:  Franziska Leiss; Julia Sabrina Götz; Günther Maderbacher; Matthias Meyer; Jan Reinhard; Florian Zeman; Joachim Grifka; Felix Greimel
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

5.  Systematic review: preoperative psychological factors and total hip arthroplasty outcomes.

Authors:  John P O'Connor; Paige Holden; Joel J Gagnier
Journal:  J Orthop Surg Res       Date:  2022-10-17       Impact factor: 2.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.